{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:18:01Z","timestamp":1783178281509,"version":"3.54.6"},"reference-count":181,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012357","name":"LifeArc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["UKRI2547"],"award-info":[{"award-number":["UKRI2547"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_21046"],"award-info":[{"award-number":["MC_PC_21046"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X02363X\/1"],"award-info":[{"award-number":["MR\/X02363X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/X02363X\/1"],"award-info":[{"award-number":["MR\/X02363X\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011724","name":"Muscular Dystrophy UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022186","name":"Lily Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008721","name":"University College London Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Telethon Italy","doi-asserted-by":"publisher","award":["GSP24003A"],"award-info":[{"award-number":["GSP24003A"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.xcrm.2026.102841","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:02:56Z","timestamp":1780412576000},"page":"102841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging therapeutic strategies for mitochondrial DNA-related diseases"],"prefix":"10.1016","volume":"7","author":[{"given":"Rubing","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1020-1848","authenticated-orcid":false,"given":"Micol","family":"Falabella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Aref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Minczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Viscomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.S.","family":"Pitceathly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102841_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2026.102841_bib2","article-title":"Mitochondrial diseases: from molecular mechanisms to therapeutic advances","volume":"10","author":"Wen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2026.102841_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmedgenet-2016-103876","article-title":"De novo mtDNA point mutations are common and have a low recurrence risk","volume":"54","author":"Sallevelt","year":"2017","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/joim.13054","article-title":"Mitochondrial disease in children","volume":"287","author":"Rahman","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejpn.2024.10.009","article-title":"Mitochondrial disorder diagnosis and management- what the pediatric neurologist wants to know","volume":"54","author":"Heath","year":"2025","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.xcrm.2026.102841_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","article-title":"Sequence and organization of the human mitochondrial genome","volume":"290","author":"Anderson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2402291121","article-title":"Mitochondrial genome copy number variation across tissues in mice and humans","volume":"121","author":"Rath","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102841_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.600079","article-title":"The Dimensions of Primary Mitochondrial Disorders","volume":"8","author":"Schlieben","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cell.2020.02.051","article-title":"Mitochondrial Diseases: Hope for the Future","volume":"181","author":"Russell","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-022-00100-2","article-title":"Designing clinical trials for rare diseases: unique challenges and opportunities","volume":"2","author":"Pizzamiglio","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.xcrm.2026.102841_bib13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-022-00715-9","article-title":"Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges","volume":"18","author":"Falabella","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.xcrm.2026.102841_bib14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s12276-023-00973-7","article-title":"Trends and prospects in mitochondrial genome editing","volume":"55","author":"Phan","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41580-023-00663-2","article-title":"Base editing of organellar DNA with programmable deaminases","volume":"25","author":"Kim","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo3724","article-title":"Mitochondrial augmentation of hematopoietic stem cells in children with single large-scale mitochondrial DNA deletion syndromes","volume":"14","author":"Jacoby","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003207","article-title":"Correction of pathogenic mitochondrial DNA in patient-derived disease models using mitochondrial base editors","volume":"23","author":"Joore","year":"2025","journal-title":"PLoS Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03671-8","article-title":"Lipid nanoparticle delivery of the CRISPR\/Cas9 system directly into the mitochondria of cells carrying m.7778G>T mutation in MtDNA (mt-Atp8)","volume":"15","author":"Norota","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102841_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/jamaophthalmol.2024.5375","article-title":"Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy","volume":"143","author":"Yu-Wai-Man","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.xcrm.2026.102841_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40123-022-00611-x","article-title":"Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation","volume":"12","author":"Carelli","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.24551","article-title":"Leigh syndrome: One disorder, more than 75 monogenic causes","volume":"79","author":"Lake","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2026.102841_bib18","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1093\/hmg\/ddz153","article-title":"G-quadruplex-mediated reduction of a pathogenic mitochondrial heteroplasmy","volume":"28","author":"Naeem","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib19","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/mt.2015.126","article-title":"MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases","volume":"23","author":"Hashimoto","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.omtm.2020.10.017","article-title":"Elimination of Mutant mtDNA by an Optimized mpTALEN Restores Differentiation Capacities of Heteroplasmic MELAS-iPSCs","volume":"20","author":"Yahata","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2026.102841_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15871-y","article-title":"TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation","volume":"7","author":"Yahata","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102841_bib22","first-page":"534","article-title":"Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria","volume":"9","author":"Tanaka","year":"2002","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.xcrm.2026.102841_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/gt.2008.11","article-title":"Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes","volume":"15","author":"Alexeyev","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib24","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1093\/nar\/gkn313","article-title":"Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA","volume":"36","author":"Minczuk","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102841_bib25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/emmm.201303672","article-title":"Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations","volume":"6","author":"Gammage","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib26","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1093\/nar\/gkw676","article-title":"Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs","volume":"44","author":"Gammage","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102841_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.molcel.2018.01.034","article-title":"NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction","volume":"69","author":"Gaude","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/302546","article-title":"A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV","volume":"65","author":"Bruno","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41556-021-00840-5","article-title":"LONP-1 and ATFS-1 sustain deleterious heteroplasmy by promoting mtDNA replication in dysfunctional mitochondria","volume":"24","author":"Yang","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib30","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-3476(79)80286-3","article-title":"A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction","volume":"95","author":"Pearson","year":"1979","journal-title":"J. Pediatr."},{"key":"10.1016\/j.xcrm.2026.102841_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s13023-022-02538-9","article-title":"Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure","volume":"17","author":"Yoshimi","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.xcrm.2026.102841_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm.3261","article-title":"Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs","volume":"19","author":"Bacman","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.410160409","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome","volume":"16","author":"Pavlakis","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.xcrm.2026.102841_bib34","first-page":"1993","article-title":"MELAS","author":"El-Hattab","year":"2001"},{"key":"10.1016\/j.xcrm.2026.102841_bib35","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/s42255-023-00932-6","article-title":"Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease","volume":"5","author":"Shoop","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.xcrm.2026.102841_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13238-017-0499-y","article-title":"Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs","volume":"9","author":"Yang","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102521","article-title":"Optimization of mtDNA-targeted platinum TALENs for bi-directionally modifying heteroplasmy levels in patient-derived m.3243A>G-iPSCs","volume":"36","author":"Yahata","year":"2025","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2026.102841_bib38","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1038\/s41467-021-26746-2","article-title":"Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation","volume":"12","author":"Chung","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/15548627.2024.2437908","article-title":"Inhibition of the PI3K-AKT-MTORC1 axis reduces the burden of the m.3243A>G mtDNA mutation by promoting mitophagy and improving mitochondrial function","volume":"21","author":"Chung","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.xcrm.2026.102841_bib40","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1038\/s41467-021-26829-0","article-title":"2-Deoxy-D-glucose couples mitochondrial DNA replication with mitochondrial fitness and promotes the selection of wild-type over mutant mitochondrial DNA","volume":"12","author":"Pantic","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib41","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.celrep.2016.08.037","article-title":"A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease","volume":"16","author":"Kauppila","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102841_bib42","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/s44321-025-00231-5","article-title":"Clinically translatable mitochondrial gene therapy in muscle using tandem mtZFN architecture","volume":"17","author":"Nash","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib43","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-018-0165-9","article-title":"Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo","volume":"24","author":"Gammage","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib44","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41591-018-0166-8","article-title":"MitoTALEN reduces mutant mtDNA load and restores tRNA(Ala) levels in a mouse model of heteroplasmic mtDNA mutation","volume":"24","author":"Bacman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib45","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1038\/s41467-021-23561-7","article-title":"Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo","volume":"12","author":"Zekonyte","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr0792","article-title":"Correcting a pathogenic mitochondrial DNA mutation by base editing in mice","volume":"17","author":"Barrera-Paez","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib47","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1093\/eurheartj\/ehaf319","article-title":"Cardiomyopathy caused by mitochondrial DNA 4300A > G variant","volume":"46","author":"Sengupta","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.102841_bib48","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s42003-023-05500-y","article-title":"Correction of a homoplasmic mitochondrial tRNA mutation in patient-derived iPSCs via a mitochondrial base editor","volume":"6","author":"Chen","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib49","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041282","article-title":"From Bench to Bedside-Delivering Gene Therapy for Leber Hereditary Optic Neuropathy","volume":"12","author":"Chen","year":"2022","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib52","doi-asserted-by":"crossref","first-page":"E1238","DOI":"10.1073\/pnas.1119577109","article-title":"Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model","volume":"109","author":"Yu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102841_bib53","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ebiom.2016.07.002","article-title":"Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy","volume":"10","author":"Yang","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2026.102841_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.662838","article-title":"Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison","volume":"12","author":"Newman","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.xcrm.2026.102841_bib56","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","article-title":"Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset","volume":"128","author":"Newman","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xcrm.2026.102841_bib57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/WNO.0000000000001367","article-title":"Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study","volume":"41","author":"Biousse","year":"2021","journal-title":"J. Neuro Ophthalmol."},{"key":"10.1016\/j.xcrm.2026.102841_bib58","first-page":"434","article-title":"The phase III REFLECT trial: efficacy of bilateral gene therapy for Leber hereditary optic neuropathy (LHON) is maintained 2 years post administration","volume":"63","author":"Yu-Wai-Man","year":"2022","journal-title":"Invest. Ophth. Vis. Sci."},{"key":"10.1016\/j.xcrm.2026.102841_bib59","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awac421","article-title":"Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy","volume":"146","author":"Newman","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2026.102841_bib60","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41587-023-01791-y","article-title":"Strand-selective base editing of human mitochondrial DNA using mitoBEs","volume":"42","author":"Yi","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102841_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66600-3","article-title":"In vivo mitochondrial base editing restores genotype and visual function in a mouse model of LHON","volume":"16","author":"Kim","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib62","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/hmg\/ddt450","article-title":"Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation","volume":"23","author":"Dai","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib63","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2015.03.051","article-title":"Selective elimination of mitochondrial mutations in the germline by genome editing","volume":"161","author":"Reddy","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12929-023-00951-1","article-title":"Optimized allotopic expression of mitochondrial ND6 transgene restored complex I and apoptosis deficiencies caused by LHON-linked ND6 14484T > C mutation","volume":"30","author":"Wang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.xcrm.2026.102841_bib65","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000393","article-title":"Delineating MT-ATP6-associated disease: From isolated neuropathy to early onset neurodegeneration","volume":"6","author":"Stendel","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/CND.0000000000000422","article-title":"Neuropathy, Ataxia, and Retinitis Pigmentosa Syndrome","volume":"24","author":"Finsterer","year":"2023","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.xcrm.2026.102841_bib67","first-page":"1993","article-title":"Single Large-Scale Mitochondrial DNA Deletion Syndromes","author":"Goldstein","year":"2003"},{"key":"10.1016\/j.xcrm.2026.102841_bib68","first-page":"1993","article-title":"Single Large-Scale Mitochondrial DNA Deletion Syndromes","author":"Goldstein","year":"2003"},{"key":"10.1016\/j.xcrm.2026.102841_bib69","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708084","article-title":"mitoTev-TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels","volume":"10","author":"Pereira","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.2021050596","article-title":"Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA","volume":"33","author":"Viering","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.xcrm.2026.102841_bib73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41576-021-00432-x","article-title":"The potential of mitochondrial genome engineering","volume":"23","author":"Silva-Pinheiro","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib74","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","article-title":"Mitochondrial membrane potential","volume":"552","author":"Zorova","year":"2018","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.xcrm.2026.102841_bib75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41576-020-00284-x","article-title":"Extreme heterogeneity of human mitochondrial DNA from organelles to populations","volume":"22","author":"Stewart","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib76","first-page":"341","article-title":"A systematic review on the biochemical threshold of mitochondrial genetic variants","volume":"34","author":"Smith","year":"2024","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2026.102841_bib77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mito.2019.10.001","article-title":"A novel mutation in the mitochondrial MT-ND5 gene in a family with MELAS. The relevance of genetic analysis on targeted tissues","volume":"50","author":"Panades-de Oliveira","year":"2020","journal-title":"Mitochondrion"},{"key":"10.1016\/j.xcrm.2026.102841_bib78","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/hmg\/ddn073","article-title":"A functionally dominant mitochondrial DNA mutation","volume":"17","author":"Sacconi","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.547638","article-title":"Mutation Load of Single, Large-Scale Deletions of mtDNA in Mitotic and Postmitotic Tissues","volume":"11","author":"Jeppesen","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib80","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10545-014-9778-4","article-title":"Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease","volume":"38","author":"Broomfield","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.xcrm.2026.102841_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106466","article-title":"Modulating mitochondrial DNA mutations: factors shaping heteroplasmy in the germ line and somatic cells","volume":"185","author":"Chiaratti","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2026.102841_bib82","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708262","article-title":"mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease","volume":"10","author":"Grady","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.651639","article-title":"Leber Hereditary Optic Neuropathy: Review of Treatment and Management","volume":"12","author":"Hage","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.xcrm.2026.102841_bib84","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41580-025-00865-w","article-title":"Molecular machineries and pathways of mitochondrial protein transport","volume":"26","author":"Endo","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib85","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1091\/mbc.9.9.2375","article-title":"Evidence for the presence of 5S rRNA in mammalian mitochondria","volume":"9","author":"Magalh\u00e3es","year":"1998","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib86","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1146\/annurev-biochem-060109-092838","article-title":"Mitochondrial tRNA import and its consequences for mitochondrial translation","volume":"80","author":"Schneider","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.xcrm.2026.102841_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/science.adr3498","article-title":"Silencing mitochondrial gene expression in living cells","volume":"389","author":"Cruz-Zaragoza","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102841_bib88","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tig.2017.11.001","article-title":"Mitochondrial Genome Engineering: The Revolution May Not Be CRISPR-Ized","volume":"34","author":"Gammage","year":"2018","journal-title":"Trends Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib89","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.xcrm.2026.102841_bib90","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.gendis.2019.08.001","article-title":"Allotopic expression of mitochondrial genes: Basic strategy and progress","volume":"7","author":"Artika","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.xcrm.2026.102841_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101429","article-title":"Codon optimization is an essential parameter for the efficient allotopic expression of mtDNA genes","volume":"30","author":"Lewis","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib92","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mito.2023.09.004","article-title":"The constraints of allotopic expression","volume":"73","author":"Nieto-Panqueva","year":"2023","journal-title":"Mitochondrion"},{"key":"10.1016\/j.xcrm.2026.102841_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176795","article-title":"Selective mitochondrial DNA degradation following double-strand breaks","volume":"12","author":"Moretton","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102841_bib94","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41467-018-04131-w","article-title":"Linear mitochondrial DNA is rapidly degraded by components of the replication machinery","volume":"9","author":"Peeva","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib95","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1038\/s41467-018-04895-1","article-title":"The mitochondrial DNA polymerase gamma degrades linear DNA fragments precluding the formation of deletions","volume":"9","author":"Nissanka","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib96","doi-asserted-by":"crossref","first-page":"14392","DOI":"10.1073\/pnas.0502896102","article-title":"Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease","volume":"102","author":"Bayona-Bafaluy","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102841_bib97","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/gt.2011.196","article-title":"Manipulation of mtDNA heteroplasmy in all striated muscles of newborn mice by AAV9-mediated delivery of a mitochondria-targeted restriction endonuclease","volume":"19","author":"Bacman","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib98","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41587-019-0186-z","article-title":"Enhancing gene editing specificity by attenuating DNA cleavage kinetics","volume":"37","author":"Miller","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102841_bib99","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/s41467-019-08867-x","article-title":"Diversifying the structure of zinc finger nucleases for high-precision genome editing","volume":"10","author":"Paschon","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202310255","article-title":"Engineering of Zinc Finger Nucleases Through Structural Modeling Improves Genome Editing Efficiency in Cells","volume":"11","author":"Katayama","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102841_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ggedit.2021.100007","article-title":"TALE and TALEN genome editing technologies","volume":"2","author":"Becker","year":"2021","journal-title":"Gene and Genome Editing"},{"key":"10.1016\/j.xcrm.2026.102841_bib102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13059-024-03188-9","article-title":"Undetectable off-target effects induced by FokI catalytic domain in mouse embryos","volume":"25","author":"Xie","year":"2024","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib103","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.xcrm.2026.102841_bib104","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/14712598.2022.2070427","article-title":"Recent advances in delivering RNA-based therapeutics to mitochondria","volume":"22","author":"Yamada","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.omtn.2020.04.004","article-title":"Validation of Gene Therapy for Mutant Mitochondria by Delivering Mitochondrial RNA Using a MITO-Porter","volume":"20","author":"Kawamura","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.xcrm.2026.102841_bib106","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","article-title":"A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing","volume":"583","author":"Mok","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib107","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41467-022-27962-0","article-title":"Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases","volume":"13","author":"Lim","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib108","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.cell.2022.03.039","article-title":"Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases","volume":"185","author":"Cho","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib109","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41587-023-01910-9","article-title":"Strand-preferred base editing of organellar and nuclear genomes using CyDENT","volume":"42","author":"Hu","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102841_bib110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41421-021-00358-y","article-title":"DdCBE-mediated mitochondrial base editing in human 3PN embryos","volume":"8","author":"Chen","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.xcrm.2026.102841_bib111","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41467-021-21464-1","article-title":"Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib112","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41551-022-00968-1","article-title":"A library of base editors for the precise ablation of all protein-coding genes in the mouse mitochondrial genome","volume":"7","author":"Silva-Pinheiro","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.102841_bib113","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.molcel.2023.04.012","article-title":"A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibility","volume":"83","author":"Guo","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib114","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41467-022-28358-w","article-title":"In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue","volume":"13","author":"Silva-Pinheiro","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41421-021-00307-9","article-title":"Precision modeling of mitochondrial diseases in zebrafish via DdCBE-mediated mtDNA base editing","volume":"7","author":"Guo","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.xcrm.2026.102841_bib116","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/crispr.2021.0061","article-title":"The FusX TALE Base Editor (FusXTBE) for Rapid Mitochondrial DNA Programming of Human Cells In Vitro and Zebrafish Disease Models In Vivo","volume":"4","author":"Sabharwal","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.xcrm.2026.102841_bib117","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.molcel.2020.08.009","article-title":"Mitochondrial DNA Base Editing: Good Editing Things Still Come in Small Packages","volume":"79","author":"Bacman","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib118","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s41586-022-04836-5","article-title":"Mitochondrial base editor induces substantial nuclear off-target mutations","volume":"606","author":"Lei","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib119","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1038\/s41467-022-31745-y","article-title":"Base editing in human cells with monomeric DddA-TALE fusion deaminases","volume":"13","author":"Mok","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib120","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1089\/hum.2024.073","article-title":"Unconstrained Precision Mitochondrial Genome Editing with alphaDdCBEs","volume":"35","author":"Castillo","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib121","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41467-023-36600-2","article-title":"DddA homolog search and engineering expand sequence compatibility of mitochondrial base editing","volume":"14","author":"Mi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib122","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1016\/j.ymthe.2025.03.051","article-title":"An engineered mitoCBE facilitates efficient mitochondrial DNA editing and modified mitochondrial transfer","volume":"33","author":"Liu","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib123","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1016\/j.ymthe.2025.08.007","article-title":"High-efficiency base editing for nuclear and mitochondrial DNA with an optimized DYW-like deaminase","volume":"33","author":"Kweon","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib124","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/s41587-022-01256-8","article-title":"CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA","volume":"40","author":"Mok","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102841_bib125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41587-022-01486-w","article-title":"Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors","volume":"41","author":"Lee","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102841_bib126","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1038\/s41467-022-34784-7","article-title":"Compact zinc finger base editors that edit mitochondrial or nuclear DNA in vitro and in vivo","volume":"13","author":"Willis","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102841_bib127","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41587-025-02608-w","article-title":"Leveraging base excision repair for efficient adenine base editing of mitochondrial DNA","volume":"44","author":"Fan","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102841_bib128","article-title":"Enhanced C-To-T and A-To-G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED","volume":"11","author":"Wei","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102841_bib129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cell.2023.11.035","article-title":"Engineering TALE-linked deaminases to facilitate precision adenine base editing in mitochondrial DNA","volume":"187","author":"Cho","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41586-024-08469-8","article-title":"Precise modelling of mitochondrial diseases using optimized mitoBEs","volume":"639","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib131","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41587-025-02685-x","article-title":"Efficient mitochondrial A-to-G base editors for the generation of mitochondrial disease models","volume":"44","author":"Chen","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102841_bib132","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.molmed.2019.09.002","article-title":"Drug Development for the Therapy of Mitochondrial Diseases","volume":"26","author":"Weissig","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib133","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tips.2024.01.011","article-title":"Mitochondrial DNA competition: starving out the mutant genome","volume":"45","author":"Spinazzola","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.xcrm.2026.102841_bib134","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.cmet.2022.10.005","article-title":"Mitochondrial DNA quality control in the female germline requires a unique programmed mitophagy","volume":"34","author":"Palozzi","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102841_bib135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41586-025-08856-9","article-title":"Small molecules restore mutant mitochondrial DNA polymerase activity","volume":"642","author":"Valenzuela","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib136","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1080\/15548627.2022.2038501","article-title":"Autophagy deficiency abolishes liver mitochondrial DNA segregation","volume":"18","author":"Tostes","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.xcrm.2026.102841_bib137","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1038\/s41598-019-41464-y","article-title":"G-quadruplex dynamics contribute to regulation of mitochondrial gene expression","volume":"9","author":"Falabella","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102841_bib138","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib139","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib140","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1470-2045(16)00106-6","article-title":"Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"17","author":"Krop","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102841_bib141","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejca.2017.08.027","volume":"86","author":"Soria","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102841_bib142","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10637-019-00776-6","article-title":"Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors","volume":"38","author":"Shapiro","year":"2020","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.xcrm.2026.102841_bib143","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56686","article-title":"Nutrient status shapes selfish mitochondrial genome dynamics across different levels of selection","volume":"9","author":"Gitschlag","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2026.102841_bib144","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-024-07332-0","article-title":"Single-cell analysis reveals context-dependent, cell-level selection of mtDNA","volume":"629","author":"Kotrys","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib145","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.cmet.2018.03.002","article-title":"Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations","volume":"27","author":"Chen","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102841_bib146","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102841_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107069","article-title":"Safety, tolerability, and pharmacokinetics of intranasal 2-deoxy-D-glucose in normal healthy volunteers: A randomized, double-blind, placebo-controlled, single and multiple ascending dose phase 1 study","volume":"209","author":"Bischof","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.xcrm.2026.102841_bib148","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/s12879-022-07642-6","article-title":"2-deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial","volume":"22","author":"Bhatt","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.xcrm.2026.102841_bib149","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1038\/s41380-025-03069-y","article-title":"Glucose restriction induces degeneration of neurons with mitochondrial DNA depletion by altering ER-mitochondria calcium transfer","volume":"30","author":"Zhou","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.xcrm.2026.102841_bib150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/humupd\/dmaf004","article-title":"Genetic and reproductive strategies to prevent mitochondrial diseases","volume":"31","author":"Castelluccio","year":"2025","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.xcrm.2026.102841_bib151","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrg3966","article-title":"The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease","volume":"16","author":"Stewart","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.xcrm.2026.102841_bib152","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semcdb.2019.10.001","article-title":"Mitochondrial heteroplasmy beyond the oocyte bottleneck","volume":"97","author":"van den Ameele","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib153","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa2415539","article-title":"Mitochondrial Donation and Preimplantation Genetic Testing for mtDNA Disease","volume":"393","author":"Hyslop","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib154","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature08368","article-title":"Mitochondrial gene replacement in primate offspring and embryonic stem cells","volume":"461","author":"Tachibana","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib155","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.celrep.2012.03.011","article-title":"Rapid mitochondrial DNA segregation in primate preimplantation embryos precedes somatic and germline bottleneck","volume":"1","author":"Lee","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102841_bib156","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/humrep\/deaa308","article-title":"Germline transmission of donor, maternal and paternal mtDNA in primates","volume":"36","author":"Ma","year":"2021","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xcrm.2026.102841_bib157","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature11647","article-title":"Towards germline gene therapy of inherited mitochondrial diseases","volume":"493","author":"Tachibana","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib158","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature11800","article-title":"Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants","volume":"493","author":"Paull","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib159","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature20592","article-title":"Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations","volume":"540","author":"Kang","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib160","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1038\/s41586-019-1623-3","article-title":"Reversion after replacement of mitochondrial DNA","volume":"574","author":"Hudson","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib161","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.fertnstert.2023.02.008","article-title":"First pilot study of maternal spindle transfer for the treatment of repeated in vitro fertilization failures in couples with idiopathic infertility","volume":"119","author":"Costa-Borges","year":"2023","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xcrm.2026.102841_bib162","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.rbmo.2017.01.013","article-title":"Live birth derived from oocyte spindle transfer to prevent mitochondrial disease","volume":"34","author":"Zhang","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.xcrm.2026.102841_bib163","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.6857250","article-title":"Nuclear transplantation in the mouse embryo by microsurgery and cell fusion","volume":"220","author":"McGrath","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102841_bib164","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/genetics\/145.2.445","article-title":"Mitochondrial genotype segregation in a mouse heteroplasmic lineage produced by embryonic karyoplast transplantation","volume":"145","author":"Meirelles","year":"1997","journal-title":"Genetics"},{"key":"10.1016\/j.xcrm.2026.102841_bib165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature08958","article-title":"Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease","volume":"465","author":"Craven","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib166","doi-asserted-by":"crossref","first-page":"292","DOI":"10.24272\/j.issn.2095-8137.2023.287","article-title":"Generation of mitochondrial replacement monkeys by female pronucleus transfer","volume":"45","author":"Li","year":"2024","journal-title":"Zool. Res."},{"key":"10.1016\/j.xcrm.2026.102841_bib167","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/cr.2017.48","article-title":"Mitochondrial replacement by pre-pronuclear transfer in human embryos","volume":"27","author":"Wu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2026.102841_bib168","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nature18303","article-title":"Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease","volume":"534","author":"Hyslop","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib169","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41551-022-00881-7","article-title":"Reduction of mtDNA heteroplasmy in mitochondrial replacement therapy by inducing forced mitophagy","volume":"6","author":"Fan","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.102841_bib170","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJMoa2503658","article-title":"Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease","volume":"393","author":"McFarland","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib171","first-page":"2955","article-title":"Biased inheritance of mitochondria during asymmetric cell division in the mouse oocyte","volume":"126","author":"Dalton","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.xcrm.2026.102841_bib172","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2014.04.042","article-title":"Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases","volume":"157","author":"Wang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib173","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/cr.2017.67","article-title":"Polar bodies are efficient donors for reconstruction of human embryos for potential mitochondrial replacement therapy","volume":"27","author":"Wu","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2026.102841_bib174","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.stem.2016.10.001","article-title":"Functional Human Oocytes Generated by Transfer of Polar Body Genomes","volume":"20","author":"Ma","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2026.102841_bib175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41422-020-0381-y","article-title":"Mitochondrial replacement in macaque monkey offspring by first polar body transfer","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.xcrm.2026.102841_bib176","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1002\/mco2.217","article-title":"Earlier second polar body transfer and further mitochondrial carryover removal for potential mitochondrial replacement therapy","volume":"4","author":"Li","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.xcrm.2026.102841_bib177","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202211044","article-title":"Mitochondria on the move: Horizontal mitochondrial transfer in disease and health","volume":"222","author":"Dong","year":"2023","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102841_bib178","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41392-024-02081-y","article-title":"Engineered mitochondria in diseases: mechanisms, strategies, and applications","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2026.102841_bib179","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41586-024-07340-0","article-title":"Mitochondrial transfer mediates endothelial cell engraftment through mitophagy","volume":"629","author":"Lin","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102841_bib180","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41536-021-00167-7","article-title":"Mitochondrial augmentation of CD34(+) cells from healthy donors and patients with mitochondrial DNA disorders confers functional benefit","volume":"6","author":"Jacoby","year":"2021","journal-title":"npj Regen. Med."},{"key":"10.1016\/j.xcrm.2026.102841_bib181","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","article-title":"The power and potential of mitochondria transfer","volume":"623","author":"Borcherding","year":"2023","journal-title":"Nature"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126002582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:50:26Z","timestamp":1783176626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126002582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":181,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666379126002582"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102841","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging therapeutic strategies for mitochondrial DNA-related diseases","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102841"}}